检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:周振华[1] 刘鲁明[1] 黄雯霞[1] 于尔辛[1] 宋明志[1]
机构地区:[1]复旦大学附属肿瘤医院,200032
出 处:《实用癌症杂志》2003年第4期400-402,共3页The Practical Journal of Cancer
摘 要:目的 探讨肝动脉介入化疗结合三维适形反应 ,治疗原发性肝癌和转移性肝癌的疗效。方法 对符合入组条件的 2 4例肝癌患者 ,先采用肝动脉介入化疗 1~ 3次 ,再进行三维适形放疗 ,肿瘤剂量 2Gy/次 ,1次 /天 ,5天 /周 ,剂量范围 (5 0± 9)Gy。放疗结束后 1个月进行疗效评价 ,应用WHO分度标准评价不良反应。结果 PR 3例 ,MR 6例 ,SD 15例 ,无CR、PD病例。肝功能异常 1例 ,上消化道出血 3例 ,Ⅰ~Ⅱ度骨髓功能抑制 16例 ,发热 1例。结论 肝动脉介入化疗结合三维适形放疗对原发性和转移性肝癌是安全。Objective To evaluate the response and tolerance of patients with intrahepatic malignancies treated by three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization.Methods Twenty-four patients with primary hepatocellular carcinoma and lung,gallbladder,colorectal,breast,pancreas and nasopharynx metastases were enrolled in the present study.All patients underwent transcatheter arterial chemoembolization(TACE).At an interval of about one month,conformal radiotherapy was given.Radiation was given five times a week at 2 Gy per day.Radiation dose to the target volume was 50±9 Gy.The response was assessed one month after the completion of treatment.The toxicity of therapy were evaluated by criterion of WHO.Results Partial response was observed in 3 patients and minimal response in 6 patients.Stable disease was observed in 15 patients.Neither complete response nor progressive disease was observed.One patient developed radiation-induced liver disease.The gastrointestinal bleeding occurred in three patients.Grade 1~2 leucopenia,anaemia and thrombocytopenia were observed in 16 patients(16/24),5 patients(5/24) and 6 patients(6/24) respectively.One patient developed fever.Conclusion Three-dimensional conformal radiotherapy combined with Transcatheter arterial chemoembolization is a safe and effective treatment for liver cancer.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222